Lexology October 24, 2024
Cozen O'Connor

  • New Jersey AG Matthew Platkin announced the adoption of new rules designed to promote greater transparency in prescription drug pricing.
  • The new rules implement recently enacted legislation intended to control prescription costs by imposing registration, reporting, and compliance requirements on manufacturers, insurance carriers, wholesalers, and other entities, who will be required to provide the AG’s office with information about drugs with significant price increases or high launch prices.
  • The AG’s...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Govt Agencies, Pharma, Pharma / Biotech, States
Related Articles:
Massachusetts Enacts Largest Health Care Transactions and Financial Oversight Legislation In a Decade, Private Investors and Provider Activities in Focus
Medicaid portals restored after federal aid freeze: 10 things to know
New York Poised to Transform Health Data Privacy
Trump’s Funding ‘Pause’ Throws States, Health Industry Into Chaos
Supplier Concentration In Medicaid Managed Care: A Cause For Concern

Share This Article